Marketing Authorization of Medicines Approved In Eu Via “Adaptive Pathway”- Consequences on The Egyptian Public Health
May 1, 2016, 00:00
10.1016/j.jval.2016.03.749
https://www.valueinhealthjournal.com/article/S1098-3015(16)00817-2/fulltext
Title :
Marketing Authorization of Medicines Approved In Eu Via “Adaptive Pathway”- Consequences on The Egyptian Public Health
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)00817-2&doi=10.1016/j.jval.2016.03.749
First page :
A289
Section Title :
Health Care Use & Policy Studies - Regulation of Health Care Sector
Open access? :
No
Section Order :
1166